PMID Title Journal Publication Year Author View in RVdb
14062086 THE ROLE OF IMMUNITY IN THE COMMON COLD AND RELATED VIRAL RESPIRATORY INFECTIONS. Med Clin North Am 1963 LEFKOWITZ LB Jr;JACKSON GG;DOWLING HF View More
14064939 LABORATORY AND VOLUNTEER STUDIES ON SOME VIRUSES ISOLATED FROM COMMON COLDS (RHINOVIRUSES). Am Rev Respir Dis 1963 TAYLOR-ROBINSON D View More
14102901 VIROLOGIC STUDIES ON ACUTE RESPIRATORY DISEASE IN YOUNG ADULTS. II. CHARACTERISTICS AND SEROLOGIC STUDIES OF THREE NEW RHINOVIRUSES. J Lab Clin Med 1964 CONNELLY AP Jr;HAMRE D View More
14105232 STUDIES WITH RHINOVIRUSES IN VOLUNTEERS: PRODUCTION OF ILLNESS, EFFECT OF NATURALLLY ACQUIRED ANTIBODY, AND DEMONSTRATION OF A PROTECTIVE EFFECT NOT ASSOCIATED WITH SERUM ANTIBODY. J Clin Invest 1964 CATE TR;COUCH RB;JOHNSON KM View More
14233470 EPIDEMIOLOGIC INVESTIGATIONS OF RHINOVIRUS INFECTIONS. Proc Soc Exp Biol Med 1964 HAMPARIN VV;LEAGUS MB;HILLEMAN MR;STOKES J Jr View More
14244718 RHINOVIRUSES AND RESPIRATORY DISEASE. Bacteriol Rev 1964 GWALTNEY JM Jr;JORDAN WS Jr View More
14294414 PREPARATION AND STANDARDIZATION OF COXSACKIEVIRUS REFERENCE ANTISERA. I. FOR TWENTY-FOUR GROUP A VIRUSES. Am J Epidemiol 1965 KAMITSUKA PS;LOU TY;FABIYI A;WENNER HA View More
14329852 A NEW TYPE OF MENINGO-ENCEPHALITIS ASSOCIATED WITH A RHINOVIRUS. Acta Paediatr Scand 1965 HOLZEL A;SMITH PA;TOBIN JO View More
23994667 Bisphenol A and human health: a review of the literature. Reprod Toxicol 2013 Rochester JR View More
28356234 Efficacy of novel antibody-based drugs against rhinovirus infection: In vitro and in vivo results. Antiviral Res 2017 Petrova NV;Emelyanova AG;Gorbunov EA;Edwards MR;Walton RP;Bartlett NW;Aniscenko J;Gogsadze L;Bakhsoliani E;Khaitov MR;Johnston SL;Tarasov SA;Epstein OI View More
29309618 Single-Cell Tracking Reveals a Role for Pre-Existing CCR5+ Memory Th1 Cells in the Control of Rhinovirus-A39 After Experimental Challenge in Humans. J Infect Dis 2018 Muehling LM;Turner RB;Brown KB;Wright PW;Patrie JT;Lahtinen SJ;Lehtinen MJ;Kwok WW;Woodfolk JA View More
30722024 Evidence for Cross-Protection Against Subsequent Febrile Respiratory Illness Episodes From Prior Infections by Different Viruses Among Singapore Military Recruits 2009-2014. J Infect Dis 2019 Chen IM;Loh JP;Chuah CXP;Gao QHC;Sun Y;Ng SH;Koh WV;Goh EH;Zhao X;Tambyah PA;Cook AR;Chng J;Pang J;Tan BH;Lee VJ View More
31003914 Epitope mapping of antibodies induced with a conserved rhinovirus protein generating protective anti-rhinovirus immunity. Vaccine 2019 Sam Narean J;Glanville N;Nunn CM;Niespodziana K;Valenta R;Johnston SL;McLean GR View More
31211158 Live-Attenuated Respiratory Syncytial Virus Vaccine With Deletion of RNA Synthesis Regulatory Protein M2-2 and Cold Passage Mutations Is Overattenuated. Open Forum Infect Dis 2019 Cunningham CK;Karron R;Muresan P;McFarland EJ;Perlowski C;Libous J;Thumar B;Gnanashanmugam D;Moye J Jr;Schappell E;Barr E;Rexroad V;Aziz M;Deville J;Rutstein R;Yang L;Luongo C;Collins P;Buchholz U View More
31464554 Vaccine strategies to induce broadly protective immunity to rhinoviruses. Hum Vaccin Immunother 2020 McLean GR View More
31486426 [Clinical and some biochemical features of rhinosinusitis of different etiology]. Vestn Otorinolaringol 2019 Ivanov MO;Maksimenya MV;Karavaeva TM;Fefelova EV;Egorova EV;Tsybikov NN View More
31758177 Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children. J Infect Dis 2020 McFarland EJ;Karron RA;Muresan P;Cunningham CK;Libous J;Perlowski C;Thumar B;Gnanashanmugam D;Moye J;Schappell E;Barr E;Rexroad V;Fearn L;Spector SA;Aziz M;Cielo M;Beneri C;Wiznia A;Luongo C;Collins P;Buchholz UJ View More
31767621 Deep Characterization of the Human Antibody Response to Natural Infection Using Longitudinal Immune Repertoire Sequencing. Mol Cell Proteomics 2020 Mitsunaga EM;Snyder MP View More
31783022 Antibody microarray immunoassay for screening and differential diagnosis of upper respiratory tract viral pathogens. J Immunol Methods 2020 Plotnikova MA;Klotchenko SA;Lebedev KI;Lozhkov AA;Taraskin AS;Gyulikhandanova NE;Ramsay ES;Vasin AV View More
32033844 Respiratory viral infection in lung transplantation induces exosomes that trigger chronic rejection. J Heart Lung Transplant 2020 Gunasekaran M;Bansal S;Ravichandran R;Sharma M;Perincheri S;Rodriguez F;Hachem R;Fisher CE;Limaye AP;Omar A;Smith MA;Bremner RM;Mohanakumar T View More
32516952 The Dynamic Life of Virus Capsids. Viruses 2020 Sherman MB;Smith HQ;Smith TJ View More
32700671 Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2. Euro Surveill 2020 Zheng Z;Monteil VM;Maurer-Stroh S;Yew CW;Leong C;Mohd-Ismail NK;Cheyyatraivendran Arularasu S;Chow VTK;Lin RTP;Mirazimi A;Hong W;Tan YJ View More
33668934 Mechanisms of Rhinovirus Neutralisation by Antibodies. Viruses 2021 Touabi L;Aflatouni F;McLean GR View More
33767706 The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic. Front Immunol 2021 Shah P;Canziani GA;Carter EP;Chaiken I View More
33920339 Generation of Antibodies against Foot-and-Mouth-Disease Virus Capsid Protein VP4 Using Hepatitis B Core VLPs as a Scaffold. Life (Basel) 2021 Swanson J;Fragkoudis R;Hawes PC;Newman J;Burman A;Panjwani A;Stonehouse NJ;Tuthill TJ View More
33935300 [SARS-CoV-2 infections and the autonomic nervous system]. Monatsschr Kinderheilkd 2021 Buchhorn R;Willaschek C;Baumann C View More
34276652 Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update. Front Immunol 2021 Anand U;Jakhmola S;Indari O;Jha HC;Chen ZS;Tripathi V;Perez de la Lastra JM View More
34442723 Cross-Reactive Immune Responses toward the Common Cold Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Mini-Review and a Murine Study. Microorganisms 2021 Sealy RE;Hurwitz JL View More
34624714 Bioinformatics analysis of rhinovirus capsid proteins VP1-4 sequences for cross-serotype vaccine development. J Infect Public Health 2021 Alshrari AS;Hudu SA;Asdaq SMB;Ali AM;Kin CV;Omar AR;Pei CP;Sekawi Z View More
34696505 Methods to Measure Antibody Neutralization of Live Human Coronavirus OC43. Viruses 2021 Boonyaratanakornkit J;Sholukh AM;Gray M;Bossard EL;Ford ES;Corbett KS;Corey L;Taylor JJ View More
34804698 Cardiac Autonomic Modulation and Anti-Thyroid Peroxidase (TPO) Antibodies in Subclinical Hypothyroidism: Does a Correlation Exist? Cureus 2021 Mavai M;Bhandari B;Singhal A;Mathur SK View More
35328398 Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins. Int J Mol Sci 2022 Tajuelo A;Lopez-Siles M;Mas V;Perez-Romero P;Aguado JM;Briz V;McConnell MJ;Martin-Galiano AJ;Lopez D View More
37638498 Rhinoviruses A and C elicit long-lasting antibody responses with limited cross-neutralization. J Med Virol 2023 Bochkov YA;Devries M;Tetreault K;Gangnon R;Lee S;Bacharier LB;Busse WW;Camargo CA;Choi T;Cohen R;De R;DeMuri GP;Fitzpatrick AM;Gergen PJ;Grindle K;Gruchalla R;Hartert T;Hasegawa K;Khurana Hershey GK;Holt P;Homil K;Jartti T;Kattan M;Kercsmar C;Kim H;Laing IA;Le Souef PN;Liu AH;Mauger DT;Pappas T;Patel SJ;Phipatanakul W;Pongracic J;Seroogy C;Sly PD;Tisler C;Wald ER;Wood R;Lemanske RF Jr;Jackson DJ;Gern JE View More
37984763 Pre-existing cross-reactive neutralizing activity against SARS-CoV-2 and seasonal coronaviruses prior to the COVID-19 pandemic (2014-2019) with limited immunity against recent emerging SARS-CoV-2 variants, Vietnam. Int J Infect Dis 2023 Nguyen TTN;Choo EM;Nakamura Y;Suzuki R;Shiina T;Shin-I T;Fukuta M;Nguyen CT;Nguyen TTT;Nguyen LKH;Hoang VMP;Morita K;Dang DA;Hasebe F;Le TQM;Moi ML View More